Discordant amyloid-β PET and CSF biomarkers and its clinical consequencesWilde, Arno de; Reimand, Juhan; Teunissen, Charlotte E.; Zwan, MarissaAlzheimer's Research & Therapy2019 / art. 78, 13 p. : ill https://doi.org/10.1186/s13195-019-0532-x Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

Insulin fibrillization at acidic and physiological pH values is controlled by different molecular mechanismsNoormägi, Andra; Valmsen, Karin; Tõugu, Vello; Palumaa, PeepThe protein journal2015 / p. 398-403 : ill http://dx.doi.org/10.1007/s10930-015-9634-x

Interference of low-molecular substances with the thioflavin-T fluorescence assay of amyloid fibrilsNoormägi, Andra; Primar, Kateryna; Tõugu, Vello; Palumaa, PeepJournal of peptide science2012 / p. 59-64 : ill

Metals in ALS TDP-43 pathologyKoski, Lassi; Ronnevi, Cecilia; Berntsson, Elina; Wärmländer, Sebastian K. T. S.; Roos, Per M.International Journal of Molecular Sciences2021 / Art. nr. 12193 https://doi.org/10.3390/ijms222212193 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

Why is amyloid-β PET requested after performing CSF biomarkers?Reimand, Juhan; Groot, Colin; Teunissen, Charlotte E.; Windhorst, Albert D.; Boellaard, Ronald; Barkhof, Frederike; Nazarenko, Sergei; van der Flier, Wiesje M.; Scheltens, Philip; Ossenkoppele, Rik; Bouwman, FemkeJournal of Alzheimer's disease2020 / p. 559-569 https://doi.org/10.3233/JAD-190836 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS